Authors: Mazzoran, L Zorat, F Chemello, L Croce, LS Rigato, I Cavalletto, L Bernardinello, E Tiribelli, C Alberti, A Pozzato, G

Citation: L. Mazzoran et al., Human leucocyte interferon-alpha in the treatment of chronic hepatitis C, DIG LIVER D, 33(4), 2001, pp. 347-352

Authors: Benvegnu, L Noventa, F Bernardinello, E Pontisso, P Gatta, A Alberti, A

Citation: L. Benvegnu et al., Evidence for an association between the aetiology of cirrhosis and patternof hepatocellular carcinoma development, GUT, 48(1), 2001, pp. 110-115

Authors: Cavalletto, L Chemello, L Donada, C Casarin, P Belussi, F Bernardinello, E Marino, F Pontisso, P Gatta, A Alberti, A

Citation: L. Cavalletto et al., The pattern of response to interferon alpha (alpha-IFN) predicts sustainedresponse to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C, J HEPATOL, 33(1), 2000, pp. 128-134

Authors: Chemello, L Cavalletto, L Bernardinello, E Boccato, S Casarin, P Cavinato, F Urban, F Pontisso, P Cecchetto, A Gatta, A Alberti, A

Citation: L. Chemello et al., Comparison of thrice weekly vs daily human leucocyte interferon-alpha therapy for chronic hepatitis C, J VIRAL HEP, 6(4), 1999, pp. 321-327

Authors: Bernardinello, E Cavalletto, L Chemello, L Mezzocolli, I Donada, C Benvegnu, L Merkel, C Gatta, A Alberti, A

Citation: E. Bernardinello et al., Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C, HEP-GASTRO, 46(30), 1999, pp. 3216-3222